dihexa administration method Buy 15mg | Third-Party Tested DIHEXA 30ML LIQUID (20MG/ML, 600MG

mg describes medication amount

For labs with variable storage conditions or longer project timelines, this format provides meaningful protection against degradation

But compelling preclinical data does not translate reliably to human outcomes

Using unregulated "research chemical" products with unknown purity, incorrect concentrations, and potential contamination (bacterial endotoxins, heavy metals, residual solvents) introduces risks that have nothing to do with the peptide

This synthetic peptide requires careful handling at every stage

Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval